Adnan O Abu-Yousif

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Top Venues

Cancer research communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Erik H Knelson, Elena V Ivanova, Mubin Tarannum, Marco Campisi, Patrick H Lizotte, Matthew A Booker, Ismail Ozgenc, Moataz Noureddine, Brittany Meisenheimer, Minyue Chen, Brandon Piel, Nathaniel Spicer, Bonje N Obua, Cameron M Messier, Erin Shannon, Navin R Mahadevan, Tetsuo Tani, Pieter J Schol, Anna M Lee-Hassett, Ari Zlota, Ha V Vo, Minh Ha, Arrien A Bertram, Saemi Han, Tran C Thai, Corinne E Gustafson, Kartika Venugopal, Timothy J Haggerty, Thomas P Albertson, Antja-Voy Hartley, Pınar Özden Eser, Ze-Hua Li, Israel Cañadas, Marina Vivero, Assunta De Rienzo, William G Richards, Adnan O Abu-Yousif, Vicky A Appleman, Richard C Gregory, Alexander Parent, Neil Lineberry, Eric L Smith, Pasi A Janne, Juan J Miret, Michael Yevgeniy Tolstorukov, Rizwan Romee, Cloud P Paweletz, Raphael Bueno, David A Barbie
Activation of Tumor-Cell STING Primes NK-Cell Therapy. Cancer immunology research 10 (8) (2022)
Elizabeth Carideo Cunniff, Yosuke Sato, Doanh Mai, Vicky A Appleman, Shinji Iwasaki, Vihren Kolev, Atsushi Matsuda, Judy Shi, Michiyo Mochizuki, Masato Yoshikawa, Jian Huang, Luhua Shen, Satyajeet Haridas, Vaishali Shinde, Chris Gemski, Emily R Roberts, Omid Ghasemi, Hojjat Bazzazi, Saurabh Menon, Tary Traore, Pu Shi, Tennille D Thelen, Joseph Conlon, Adnan O Abu-Yousif, Christopher Arendt, Michael H Shaw, Masanori Okaniwa
TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies. Cancer research communications 2 (6) (2022)